Andrew Getahun

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 9

Top Topics

Aortic Dissection

Circulating Tumor Cells

Signaling Pathway

Acute Lymphoblastic Leukemia

Top Venues

Journal of immunology (Baltimore, Md. : 1950)

The Journal of experimental medicine

Immunological reviews

bioRxiv : the preprint server for biology

This page only lists publications with an associated author ORCID identifier.

Publications

Brigita E Fiske, Andrew Getahun
Failed Downregulation of PI3K Signaling Makes Autoreactive B Cells Receptive to Bystander T Cell Help. Journal of immunology (Baltimore, Md. : 1950) 212 (7) (2024)
Brigita E Fiske, Andrew Getahun
Failed Downregulation of PI3K Signaling Makes Autoreactive B Cells Receptive to Bystander T Cell Help. Journal of immunology (Baltimore, Md. : 1950) (2024)
Brigita E Fiske, Andrew Getahun
Failed Downregulation of PI3K Signaling Makes Autoreactive B Cells Receptive to Bystander T Cell Help. Journal of immunology (Baltimore, Md. : 1950) (2024)
Brigita E Fiske, Andrew Getahun
Failed down-regulation of PI3K signaling makes autoreactive B cells receptive to bystander T cell help. bioRxiv : the preprint server for biology (2023)
Scott M Wemlinger, Chelsea R Parker Harp, Bo Yu, Ian R Hardy, Matthew Seefeldt, Jennifer Matsuda, Michael Mingueneau, Kerri A Spilker, Thomas O Cameron, James W Larrick, Andrew Getahun, John C Cambier
Preclinical Analysis of Candidate Anti-Human CD79 Therapeutic Antibodies Using a Humanized CD79 Mouse Model. Journal of immunology (Baltimore, Md. : 1950) 208 (7) (2022)
Andrew Getahun
Role of inhibitory signaling in peripheral B cell tolerance. Immunological reviews 307 (1) (2022)
S Elizabeth Franks, Andrew Getahun, John C Cambier
A Precision B Cell-Targeted Therapeutic Approach to Autoimmunity Caused by Phosphatidylinositol 3-Kinase Pathway Dysregulation. Journal of immunology (Baltimore, Md. : 1950) 202 (12) (2019)
Melissa M Walker, Bergren W Crute, John C Cambier, Andrew Getahun
B Cell-Intrinsic STING Signaling Triggers Cell Activation, Synergizes with B Cell Receptor Signals, and Promotes Antibody Responses. Journal of immunology (Baltimore, Md. : 1950) 201 (9) (2018)
Andrew Getahun, Scott M Wemlinger, Pratyaydipta Rudra, Mario L Santiago, Linda F van Dyk, John C Cambier
Impaired B cell function during viral infections due to PTEN-mediated inhibition of the PI3K pathway. The Journal of experimental medicine 214 (4) (2017)